Health Care: Drugs

Clovis Oncology Inc (CLVS: NASDAQ)

$12.355 n/a | n/a%
06/28/16 - 04:00 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 0.00 13.62M 0.00 0.00
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 0.00 13.62M 0.00 0.00
Selling, General, and Administrative Expenses 30.52M 21.46M 16.57M 10.64M
Research & Development 269.25M 137.71M 66.55M 58.89M
Operating Income before D & A (EBITDA) -299.77M -145.54M -83.11M -69.53M
Depreciation & Amortization 3.37M 4.22M 250.00K 363.00K
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net 3.16M 2.63M -1.12M -228.00K
Special Income / Charges -88.95M -21.02M -500.00K -8.50M
Total Income Before Interest Expenses (EBIT) -376.93M -159.34M -84.73M -74.37M
Interest Expense 8.37M 2.60M 0.00 0.00
Pre-Tax Income -385.30M -161.94M -84.73M -74.37M
Income Taxes -29.08M 2.31M 52.00K -27.00K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -352.86M -160.03M -84.53M -73.98M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -352.86M -160.03M -84.53M -73.98M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -352.86M -160.03M -84.53M -73.98M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-275.92M -147.82M -84.28M -69.73M
Preferred Dividends
Net Income Available To Common -352.86M -160.03M -84.53M -73.98M
Basic EPS from Continuing Ops. -9.79 -4.72 -2.95 -2.97
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -9.79 -4.72 -2.95 -2.97
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -9.79 -4.72 -2.95 -2.97
Basic Normalized Net Income/Share -7.66 -4.36 -2.94 -2.80
EPS fr Continuing Ops. -9.79 -4.72 -2.95 -2.97
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -9.79 -4.72 -2.95 -2.97
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -9.79 -4.72 -2.95 -2.97
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-7.66 -4.36 -2.94 -2.80
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with CLVS

Latest CLVS Headlines from TheStreet

More Financial News for CLVS

Press Releases for CLVS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter